Danila U. Seidel

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

Journal: Antimicrobial agents and chemotherapy

Published: May 12, 2026

30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Journal: Annals of hematology

Published: April 02, 2026

Complement inhibitor therapy in atypical hemolytic uremic syndrome (aHUS): evaluating the economic impact of introducing eculizumab biosimilars in Germany.

Complement inhibitor therapy in atypical hemolytic uremic syndrome (aHUS): evaluating the economic impact of introducing eculizumab biosimilars in Germany.

Journal: BMC nephrology

Published: March 16, 2026

Global Review on Naegleria fowleri Cases: Contemporary Epidemiology, Diagnosis, Treatment and Outcomes.

Global Review on Naegleria fowleri Cases: Contemporary Epidemiology, Diagnosis, Treatment and Outcomes.

Journal: Infectious disease reports

Published: January 26, 2026

CAMEO-a cross-sectional survey study on candidemia management in Germany.

CAMEO-a cross-sectional survey study on candidemia management in Germany.

Journal: Medical mycology

Published: January 09, 2026

Association of autoimmune diseases with chronic rhinosinusitis in general practices in Germany.

Association of autoimmune diseases with chronic rhinosinusitis in general practices in Germany.

Journal: Rhinology

Published: January 05, 2026

Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany.

Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany.

Journal: Emerging infectious diseases

Published: December 11, 2025

Effects of Antifungal Treatment in COVID-19-Associated Pulmonary Aspergillosis: A European Multicenter Cohort Study.

Effects of Antifungal Treatment in COVID-19-Associated Pulmonary Aspergillosis: A European Multicenter Cohort Study.

Journal: Chest

Published: September 30, 2025

Sequential serum galactomannan as outcome marker for invasive aspergillosis-An exploratory study from the FungiScope registry.

Sequential serum galactomannan as outcome marker for invasive aspergillosis-An exploratory study from the FungiScope registry.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 06, 2025

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.

Journal: Infection

Published: August 21, 2025

Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational study.

Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 14, 2025

Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States.

Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States.

Journal: Mycoses

Published: July 22, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026